The trajectory of the erectile dysfunction drug presents a challenging picture for investors. While the initial launch generated significant gains, the expiration of its intellectual property protection opened the https://lorindsp660559.smblogsites.com/41900511/viagra-and-big-pharma-a-precarious-bet